Chenxin Company has independent research and development capabilities for drugs, and has established long-term relationships with scientific research institutes such as China Pharmaceutical University, Shenyang Pharmaceutical University, Shandong University, Shandong Academy of Medical Sciences, and Shandong Pharmaceutical Industry Research Institute. The cooperative relationship has successfully created a path of "joint innovation among industry, academia and research". The company has now established a one-stop development system from market research, development and design to trial production, forming a virtuous cycle of developing one generation, reserving one generation, and producing one generation.
At present, it has successfully developed more than 60 new varieties, including 8 Class II new drugs and 36 Class IV new drugs. It has obtained more than 60 new drug certificates and more than 90 production approval documents. 5 varieties won provincial and municipal science and technology progress awards, 1 was rated as a national key new variety, 12 varieties passed provincial appraisal, and 4 were included in the Shandong Provincial High-tech Product Catalog. It has 6 national patents, including 2 invention patents and 1 utility model patent. Currently, 13 technologies have applied for national patents and have been accepted by the National Patent Office.